# IMMIX BIOPHARMA, INC. hires BROWNSTEIN HYATT FARBER SCHRECK, LLP (Pharmacy, Health Issues)

**Score:** 90/100

| Field | Value |
|---|---|
| Client | IMMIX BIOPHARMA, INC. |
| Client description | Biopharmaceutical company |
| Client state | CA |
| Lobbying firm | BROWNSTEIN HYATT FARBER SCHRECK, LLP |
| Firm state | DC |
| Issue areas | Pharmacy, Health Issues |
| Specific matters disclosed | Issues surrounding biopharmaceutical research, development, and regulatory policy and standards. · Issues surrounding biopharmaceutical research, development, and regulatory policy and standards. |
| Registered | 2026-11-04 |

## Why this score
- Registered in the last two weeks.
- Lobbying on several issue areas.
- Specific matters disclosed.

Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/96868e52-372c-4e9e-a296-748a87fab7a6/print/). Last refreshed: 2026-11-06T02:50:59.808Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.